Zydus Therapeutics Inc.
Clinical trials sponsored by Zydus Therapeutics Inc., explained in plain language.
-
New study checks how liver disease affects drug processing
Knowledge-focused Recruiting nowThis early-stage study looks at how the drug saroglitazar is handled by the body in people with moderate liver damage from cholestatic liver disease. Six adults with cirrhosis will take the drug every other day, and researchers will measure drug levels and watch for side effects.…
Phase: PHASE1 • Sponsor: Zydus Therapeutics Inc. • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:52 UTC
-
Liver study tests how drug moves in body with scarred livers
Knowledge-focused Recruiting nowThis study looks at how the drug Saroglitazar is processed in people with mild, moderate, or severe liver scarring (cirrhosis) caused by cholestatic liver disease. About 30 adults will take 1 mg or 2 mg doses daily for 28 days. Researchers will measure drug levels in the blood an…
Phase: PHASE1 • Sponsor: Zydus Therapeutics Inc. • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:05 UTC